Acadia Pharmaceuticals Inc (ACAD)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Baker Bros. Advisors

Julian Baker And Felix Baker

41,923,486 $590,702 +1% 3.35%
2.
EcoR1 Capital

Oleg Nodelman

5,991,479 $84,420 2.91%
3.
D E Shaw

D. E. Shaw

4,686,665 $66,035 +4% 0.07%
4. 1,733,130 $24,420 1.6%
5.
Palo Alto Investors

William Leland Edwards

1,678,196 $23,646 -26% 2.06%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$34.47 42,473 Large Shareholder, Director 38,433,977 2020-03-18 Filing
$34.47 3,837 Large Shareholder, Director 3,470,609 2020-03-18 Filing
$33.63 33,464 Large Shareholder, Director 38,391,504 2020-03-18 Filing
$33.63 3,023 Large Shareholder, Director 3,466,772 2020-03-18 Filing
$32.85 2,201 Large Shareholder, Director 38,358,040 2020-03-18 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.91 653 Officer 3,342 2022-06-09 Filing
$18.18 5,483 Officer, Director 75,875 2022-05-02 Filing
$18.18 2,865 Officer 55,188 2022-05-02 Filing
$18.18 894 Officer 16,742 2022-05-02 Filing
$18.18 552 Officer 3,437 2022-05-02 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 614,537 $8,658,826 0%
2. 202,652 $2,855,366 0.02%
3. 54,787 $771,949 0%
4. 46,171 $651,011 0%
5. 12,400,593 $174,724 0%
News See All